COSMOS Pharmaceutical Beheer
Beheer criteriumcontroles 0/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Hideaki Yokoyama
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 7.3yrs |
Eigendom CEO | 0.03% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Sep 26An Intrinsic Calculation For COSMOS Pharmaceutical Corporation (TSE:3349) Suggests It's 41% Undervalued
Aug 17COSMOS Pharmaceutical (TSE:3349) Will Want To Turn Around Its Return Trends
Aug 01Subdued Growth No Barrier To COSMOS Pharmaceutical Corporation's (TSE:3349) Price
Jun 28We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Jun 10COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 17Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio
Mar 16Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture
Feb 28CEO
Hideaki Yokoyama (44 yo)
7.3yrs
Tenure
Mr. Hideaki Yokoyama has been President at COSMOS Pharmaceutical Corporation since June 2018 and served as its General Manager of Sales Division and Head of Store Operations since August 2017. Mr. Yokoyama...